Optic Nerve Glioma - 10 Studies Found
| Withdrawn | 
                                    : Phase 3 Study of ANP Therapy vs. TMZ for Optic Pathway Glioma : Optic Nerve Glioma : 2010-12-13 : 
  | 
                                
| Active, not recruiting | 
                                    : PET/MRI in CNS and Extra-CNS Tumors of Patients With Neurofibromatosis-1 (NF1) : 
  | 
                                
| Withdrawn | 
                                    : Autologous Stem Cell Collection and Reinfusion in Newly Diagnosed High Grade Gliomas : 
  | 
                                
| Completed | 
                                    : Phase II Pegylated Interferon : 
 : 2015-01-08 : Drug: Pegylated interferon alpha-2b PEG-Intron 1mcg/kg/dose weekly through an injection under the skin o  | 
                                
| Not yet recruiting | 
                                    : Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Dermal Neurofibroma : 
  | 
                                
| Active, not recruiting | 
                                    : Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma : 
  | 
                                
| Terminated | 
                                    : Sorafenib in Children and Young Adults With Recurrent or Progressive Low-Grade Astrocytomas : 
 : Drug: Sorafenib (Nexavar) Sorafenib (in tablet form) will  | 
                                
| Recruiting | 
                                    : Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma : 
  |